Ayahuasca and Its Main Component <i>N,N</i>-Dimethyltryptamine (DMT) for the Treatment of Mental Disorders: Mechanisms of Action, Clinical Studies, and Tools to Explore the Human Mind. [PDF]
Melani A +9 more
europepmc +1 more source
Investigating of harmane, harmine, and norharman as inhibitors of MDR1 and MRP1 to overcome chemotherapy resistance in cancer cells. [PDF]
Abdi N +5 more
europepmc +1 more source
Extraction and Characterization of <i>N</i>,<i>N</i>‑Dimethyltryptamine from <i>Mimosa tenuiflora</i>: A Multivariate Approach. [PDF]
de Oliveira LC +10 more
europepmc +1 more source
Psychedelics for major depression-From controlled research settings into broader clinical use. [PDF]
Avram M, Borgwardt S.
europepmc +1 more source
Ayahuasca enhances functional connectivity in the third visual pathway and mirror neuron networks: a crossover, multiple-dose functional MRI study. [PDF]
Soares C +6 more
europepmc +1 more source
The Role of Ayahuasca in Colorectal Adenocarcinoma Cell Survival, Proliferation and Oxidative Stress. [PDF]
Gonçalves J +5 more
europepmc +1 more source
Cardiac effects of two hallucinogenic natural products, N,N-dimethyl-tryptamine and 5-methoxy-N,N-dimethyl-tryptamine. [PDF]
Neumann J +4 more
europepmc +1 more source

